Susanne Stein

Summary

Affiliation: Frankfurt am Main
Country: Germany

Publications

  1. ncbi NDRG1 is necessary for p53-dependent apoptosis
    Susanne Stein
    Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    J Biol Chem 279:48930-40. 2004
  2. ncbi Saturation screening for p53 target genes by digital fluorescent differential display
    Yong Jig Cho
    Department of Cell Biology, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
    Methods Mol Biol 317:179-92. 2006
  3. ncbi CYFIP2, a direct p53 target, is leptomycin-B sensitive
    Roger S Jackson
    Vanderbilt Ingram Comprehensive Cancer Center, Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232 6840, USA
    Cell Cycle 6:95-103. 2007
  4. ncbi Identification of p53 target genes by fluorescent differential display
    Susanne Stein
    Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
    Methods Mol Biol 234:51-63. 2003
  5. ncbi Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro
    Harun M Said
    Department of Radiation Oncology, University of Wurzburg, 97080 Wurzburg, Germany
    Oncol Rep 20:413-9. 2008

Detail Information

Publications5

  1. ncbi NDRG1 is necessary for p53-dependent apoptosis
    Susanne Stein
    Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    J Biol Chem 279:48930-40. 2004
    ..This report further supports the notion that p53 controls a network of genes that are required for its apoptotic function...
  2. ncbi Saturation screening for p53 target genes by digital fluorescent differential display
    Yong Jig Cho
    Department of Cell Biology, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
    Methods Mol Biol 317:179-92. 2006
    ..We are using this newly integrated FDD technology to conduct a systematic and comprehensive screening for p53 tumor-suppressor gene targets...
  3. ncbi CYFIP2, a direct p53 target, is leptomycin-B sensitive
    Roger S Jackson
    Vanderbilt Ingram Comprehensive Cancer Center, Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232 6840, USA
    Cell Cycle 6:95-103. 2007
    ....
  4. ncbi Identification of p53 target genes by fluorescent differential display
    Susanne Stein
    Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
    Methods Mol Biol 234:51-63. 2003
    ....
  5. ncbi Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro
    Harun M Said
    Department of Radiation Oncology, University of Wurzburg, 97080 Wurzburg, Germany
    Oncol Rep 20:413-9. 2008
    ....